Metabolic diseases are based on a dysregulated crosstalk between various cells such as adipocytes, hepatocytes and immune cells. Generally, hormones and metabolites mediate this crosstalk that becomes alterated in metabolic syndrome including obesity and diabetes. Recently, Extracellular Vesicles (EVs) are emerging as a novel way of cell-to-cell communication and represent an attractive strategy to transfer fundamental informations between the cells through the transport of proteins and nucleic acids. EVs, released in the extracellular space, circulate via the various body fluids and modulate the cellular responses following their interaction with the near and far target cells. Clinical and experimental data support their role as biomarkers and bioeffectors in several diseases includimg also the metabolic syndrome. Despite numerous studies on the role of macrophages in the development of metabolic diseases, to date, there are little informations about the influence of metabolic stress on the EVs produced by macrophages and about the role of the released vesicles in the organism. Here, we review current understanding about the role of EVs in metabolic diseases, mainly in inflammation status burst. This knowledge may play a relevant role in health monitoring, medical diagnosis and personalized medicine.
Microvesicles and exosomes in metabolic diseases and inflammation / Dini, L; Tacconi, S; Carata, E; Tata, A M; Vergallo, C; Panzarini, E. - In: CYTOKINE & GROWTH FACTOR REVIEWS. - ISSN 1359-6101. - 51(2020), pp. 27-39.
|Titolo:||Microvesicles and exosomes in metabolic diseases and inflammation|
|Data di pubblicazione:||2020|
|Citazione:||Microvesicles and exosomes in metabolic diseases and inflammation / Dini, L; Tacconi, S; Carata, E; Tata, A M; Vergallo, C; Panzarini, E. - In: CYTOKINE & GROWTH FACTOR REVIEWS. - ISSN 1359-6101. - 51(2020), pp. 27-39.|
|Appartiene alla tipologia:||01a Articolo in rivista|